Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H24N2O2.ClH |
| Molecular Weight | 360.878 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC2=C(C=C1)N=CC=C2C(=O)CC[C@@H]3CCNC[C@@H]3C=C
InChI
InChIKey=YUBRJAHSRSIPKX-LDXVYITESA-N
InChI=1S/C20H24N2O2.ClH/c1-3-14-13-21-10-8-15(14)4-7-20(23)17-9-11-22-19-6-5-16(24-2)12-18(17)19;/h3,5-6,9,11-12,14-15,21H,1,4,7-8,10,13H2,2H3;1H/t14-,15+;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C20H24N2O2 |
| Molecular Weight | 324.4168 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Viquidil is an isomer of quinidine and papaverine derivative. Viquidil is used for treatment of disturbances of cerebral blood flow and metabolism. Viquidil, however, appeared to be approximately twice as potent as papaverine in inhibition of thrombus formation in the microvasculature and was apparently without toxic side-effects.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/582736
Curator's Comment: Hamster data
Minimum dose level - 2.5 X 10(-4) mg/kg
Route of Administration:
Parenteral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:50:19 GMT 2025
by
admin
on
Mon Mar 31 20:50:19 GMT 2025
|
| Record UNII |
U6FXT2V136
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
236343
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID30966589
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | |||
|
198279
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | |||
|
52211-63-9
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | |||
|
100000087884
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | |||
|
SUB05109MIG
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | |||
|
U6FXT2V136
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | |||
|
m11469
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY | Merck Index | ||
|
257-739-9
Created by
admin on Mon Mar 31 20:50:19 GMT 2025 , Edited by admin on Mon Mar 31 20:50:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |